Immune Response to Melanoma Extracts In Three Melanoma-Prone Families2
- 1 November 1979
- journal article
- research article
- Published by Oxford University Press (OUP) in JNCI Journal of the National Cancer Institute
- Vol. 63 (5) , 1147-1151
- https://doi.org/10.1093/jnci/63.5.1147
Abstract
Immune reactivity to melanoma extracts was measured by the leukocyte adherence Inhibition (LAI) test In 40 members of 3 melanoma-prone families. The melanoma patients had a wide range of responsiveness to the extract, the highest responder being a 10-year survivor. As a group, family members (Including spouses) without disease had significantly elevated LAI responses compared to those of unrelated controls (PP<0.05). Responses of spouses and members at high risk of developing melanoma (B-K mole syndrome) also correlated with length of exposure to patients, which suggests that the elevated LAI response was not genetically determined. The high frequency of positive responses to melanoma antigens In these families, particularly In spouses, suggests the presence of transmissible melanoma-associated material capable of Immunizing persons In contact with melanoma patlents.Keywords
This publication has 6 references indexed in Scilit:
- Immunologic Abnormalities in Melanoma-Prone Families2JNCI Journal of the National Cancer Institute, 1979
- Origin of familial malignant melanomas from heritable melanocytic lesions. 'The B-K mole syndrome'Archives of Dermatology, 1978
- Precursor lesions in familial melanoma. A new genetic preneoplastic syndromeJAMA, 1978
- Urinary amino acid excretion in acute leukemiaCancer, 1976
- SENSITISATION OF NEUROBLASTOMA PATIENTS AND RELATED AND UNRELATED CONTACTS TO NEUROBLASTOMA EXTRACTSThe Lancet, 1976
- Capillary tube leukocyte adherence inhibition: An assay for cell-mediated immunity in cancer patientsInternational Journal of Cancer, 1976